UBC researcher gets $1-million grant to study link between pot, HIV/AIDS (M-J Milloy, BC Centre for Excellence in HIV/AIDS)
A University of B.C. researcher who recently found that daily pot use might help fight HIV/AIDS is getting a $1-million grant from a commercial cannabis grower, which could lead to more clinical evidence for doctors skeptical of a drug still outlawed in Canada.
National Green BioMed, a Richmond-based company partly owned by former Liberal MP Herb Dhaliwal, has already provided $200,000. It has committed to paying the full million dollars over five years, even if it fails to secure a licence from Health Canada to grow marijuana at its Fraser Valley facility.
Mr. Dhaliwal said a team led by M. J. Milloy, an infectious-disease epidemiologist with the B.C. Centre for Excellence in HIV/AIDS, will have “all the freedom in the world” to conduct research that meets the “highest ethical standards” into the possible therapeutic benefits of cannabis.
Mike Hager reports
Dianne Doyle, President & CEO, and Geoff Plant, Chair, PHC Board of Directors